May 10, 2017 / 8:36 PM / 5 months ago

BRIEF-Immunomedics Q3 loss per share $0.55

May 10 (Reuters) - Immunomedics Inc:

* Immunomedics announces third quarter fiscal 2017 results and clinical program developments

* Q3 loss per share $0.55

* Q3 revenue $1.3 million

* Immunomedics Inc says total costs and expenses for quarter ended March 31, 2017 were $23.4 million, compared to $15.5 million for same quarter in fiscal 2016

* Immunomedics Inc says recognized a $28.3 million non-cash expense during three-month period ended March 31, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below